The former Illinois governor has been undergoing chemotherapy after a diagnosis last month, he told the Sun-Times. “I’m ...

DURIPANC is an investigator-initiated, exploratory, open-label, single-center study in the Netherlands at the Erasmus Medical ...

Ever Evaluation of SIL-204 in Clinically Relevant Orthotopic Models; Analysis Underway with Initial Results Expected in ...

Testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and ...

Shares of Candel Therapeutics , Inc. (NASDAQ: CADL) climbed 8% following the announcement of favorable final survival data from their phase 2 trial of CAN-2409, a treatment for pancreatic cancer. The ...

Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...

For millennials and Gen Z, cancer is no longer rare. Once considered something people get as they grow older, it’s become a harsh reality for younger generations. As cancer ...

Alice Rees initially put the pain under her ribs and nausea that she experienced while on holiday with friends in July 2023 ...

Pancreatic cancer remains one of the most challenging cancers to treat, but research like this could provide a much-needed ...

The information in this report is information that Immunovia AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency ...

Fear of nuclear fallout has led to a novel therapeutic approach that could significantly extend the lives of individuals with ...

Recent positive lab confirmation of Smart mRNA functionality is a tremendous milestone for the Company. This marks a ...